Psychiatry and Neurology, Neurology · Worcester, MA
NPI
1356530349
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
55 Lake Ave N, Neurology
Worcester, MA, 01655
Phone (508) 334-2527
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
373 services
Medicare patients, 2024
261
Average age 64
Drug cost, 2024
$3.9M
2,643 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Bomprezzi was code 99214 (office e&m - established), 164 times for 132 patients. In total Roberto Bomprezzi billed 373 services in 24 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 164 | 132 | $72.46 | $12K |
| 99215 Office E&M - Established | Office | 47 | 36 | $104.61 | $4,916 |
| 99213 Office E&M - Established | Office | 36 | 31 | $50.07 | $1,802 |
| 99222 Hospital E&M - Initial | Facility | 30 | 28 | $95.61 | $2,868 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 14 | $93.13 | $1,676 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $13.05 | $196 |
By year: 2022 $28K for 386 services; 2023 $29K for 375 services; 2024 $28K for 373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Bomprezzi prescribed most often to Medicare patients was Gabapentin, with 324 prescriptions and refills. In total Roberto Bomprezzi wrote 2,643 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 324 | 433 | 57 | $7,659 |
| Baclofen Generic | 215 | 398 | 51 | $4,257 |
| Kesimpta Pen Ofatumumab | 142 | 177 | 17 | $1.5M |
| Modafinil Generic | 137 | 163 | 27 | $6,347 |
| Tramadol Hcl Generic | 131 | 132 | 20 | $4,858 |
| Tizanidine Hcl Generic | 131 | 186 | 23 | $4,664 |
| Dalfampridine Er Dalfampridine | 87 | 147 | 14 | $33K |
| Pregabalin Generic | 84 | 92 | 13 | $4,873 |
| Duloxetine Hcl Generic | 66 | 107 | 14 | $906 |
| Solifenacin Succinate Generic | 60 | 111 | 15 | $3,089 |
| Lorazepam Generic | 58 | 70 | 18 | $655 |
| Clonazepam Generic | 54 | 70 | Under 11 | $473 |
| Topiramate Generic | 52 | 96 | 12 | $823 |
| Myrbetriq Mirabegron | 46 | 56 | Under 11 | $26K |
| Ropinirole Hcl Generic | 34 | 54 | Under 11 | $886 |
Brand drugs: 401 claims; generic drugs: 2,242 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Bomprezzi $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.